About half of drinkers on GLP-1s say they imbibed less

Nearly half of drinkers who take GLP-1 medications have reported declines in consumption, with the effect higher among those at risk of unhealthy alcohol use, a new Harvard study shows. The work, published in the journal JAMA Psychiatry, explores an unexpected side effect of GLP-1s used to treat diabetes and obesity.

Read it at Medical Xpress ↗

← Front page